MetaADEDB 2.0 @ LMMD
Aspirin, Dipyridamole Drug Combination
(NOHUXXDTQJPXSB-UHFFFAOYSA-N)
Structure
SMILES
CC(=O)Oc1ccccc1C(=O)O.OCCN(c1nc(N2CCCCC2)c2c(n1)c(nc(n2)N(CCO)CCO)N1CCCCC1)CCO
Molecular Formula:
C33H48N8O8
Molecular Weight:
684.783
Log P:
1.4225
Hydrogen Bond Acceptor:
16
Hydrogen Bond Donor:
5
TPSA:
209.04
CAS Number(s):
87653-67-6
Synonym(s)
1.
Aspirin, Dipyridamole Drug Combination
2.
Aggrenox
3.
Asasantin
4.
Asasantin Retard
5.
Aspirin-Dipyridamole Drug Combination
6.
Extended-Release Dipyridamole-Aspirin
7.
TX 3301
8.
TX-3301
9.
3301, TX
10.
Aspirin Dipyridamole Drug Combination
11.
Combination, Aspirin-Dipyridamole Drug
12.
Dipyridamole-Aspirin, Extended-Release
13.
Drug Combination, Aspirin-Dipyridamole
14.
Extended Release Dipyridamole Aspirin
15.
Retard, Asasantin
External Link(s)
MeSHD000068342
PubChem Compound137329
Therapeutic Target DatabaseD0F3IP
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HeadacheFAERS: 201
Canada Vigilance: 5
Canada Vigilance
US FAERS
2Cerebrovascular accidentFAERS: 154
Canada Vigilance: 1
Canada Vigilance
US FAERS
3NauseaFAERS: 85
Canada Vigilance: 1
Canada Vigilance
US FAERS
4VomitingFAERS: 68US FAERS
5DizzinessFAERS: 4312093268CTD
US FAERS
6Myocardial InfarctionFAERS: 34US FAERS
7AstheniaFAERS: 21
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
8FatigueFAERS: 19
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
9Abdominal discomfortFAERS: 17US FAERS
10Chest PainFAERS: 15US FAERS
11Feeling abnormalFAERS: 13US FAERS
12MalaiseFAERS: 13US FAERS
13PneumoniaFAERS: 13US FAERS
14Abdominal PainFAERS: 11US FAERS
15Back PainFAERS: 11US FAERS
16HypotensionFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
17ConstipationFAERS: 10US FAERS
18Drug ineffectiveFAERS: 10US FAERS
19DyspepsiaFAERS: 10US FAERS
20Atrial FibrillationFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
21Cerebral InfarctionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
22EpistaxisFAERS: 97032379CTD
US FAERS
23Product quality issueFAERS: 9US FAERS
24DementiaFAERS: 8US FAERS
25FlushingFAERS: 8US FAERS
26HypersensitivityFAERS: 8US FAERS
27MyalgiaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Blood urine presentFAERS: 7US FAERS
29ChillsFAERS: 7US FAERS
30ErythemaFAERS: 7US FAERS
31HemiparesisFAERS: 7US FAERS
32Unevaluable eventFAERS: 7US FAERS
33AgeusiaFAERS: 6US FAERS
34ArthralgiaFAERS: 6US FAERS
35Atrioventricular BlockFAERS: 6US FAERS
36ChromaturiaFAERS: 6US FAERS
37Deep Vein ThrombosisFAERS: 6US FAERS
38PruritusFAERS: 6US FAERS
39Acute myocardial infarctionFAERS: 5OFFSIDES
US FAERS
40AlopeciaFAERS: 5US FAERS
41AphasiaFAERS: 5US FAERS
42Burning sensationFAERS: 5US FAERS
43DysgeusiaFAERS: 5US FAERS
44Incorrect dose administeredFAERS: 5US FAERS
45InfectionFAERS: 5OFFSIDES
US FAERS
46NasopharyngitisFAERS: 5US FAERS
47Neck PainFAERS: 5US FAERS
48PainFAERS: 5US FAERS
49SomnolenceFAERS: 5US FAERS
50TinnitusFAERS: 5US FAERS
51UrticariaFAERS: 5US FAERS
52Weight decreasedFAERS: 5US FAERS
53Alanine Aminotransferase IncreasedFAERS: 4OFFSIDES
US FAERS
54Blood glucose increasedFAERS: 4US FAERS
55Chest discomfortFAERS: 4US FAERS
56ChokingFAERS: 4US FAERS
57Drug dispensing errorFAERS: 4US FAERS
58FlatulenceFAERS: 4US FAERS
59Joint swellingFAERS: 4US FAERS
60Medication ErrorFAERS: 4US FAERS
61OverdoseFAERS: 4US FAERS
62PalpitationsFAERS: 4US FAERS
63Pulmonary EmbolismFAERS: 4US FAERS
64PurpuraFAERS: 4US FAERS
65TachycardiaFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
66ThrombocytopeniaFAERS: 4US FAERS
67ThrombosisFAERS: 4US FAERS
68Acute Coronary SyndromeFAERS: 3US FAERS
69AgitationFAERS: 3US FAERS
70AmnesiaFAERS: 3US FAERS
71Angina PectorisFAERS: 3US FAERS
72Blood glucose abnormalFAERS: 3US FAERS
73Carotid artery occlusionFAERS: 3US FAERS
74Disease recurrenceFAERS: 3US FAERS
75DysarthriaFAERS: 3US FAERS
76DysphoniaFAERS: 3OFFSIDES
US FAERS
77EndarterectomyFAERS: 3US FAERS
78Eye irritationFAERS: 3US FAERS
79InfluenzaFAERS: 3US FAERS
80RetchingFAERS: 3US FAERS
81Suicide attemptFAERS: 3US FAERS
82Urinary tract infectionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
83Wrong technique in drug usage processFAERS: 3US FAERS
84Adverse eventFAERS: 2US FAERS
85AmaurosisFAERS: 2US FAERS
86AnxietyFAERS: 2US FAERS
87AphoniaFAERS: 2US FAERS
88Blood potassium increasedFAERS: 2US FAERS
89Bowel movement irregularityFAERS: 2US FAERS
90Cardiac ArrestFAERS: 2US FAERS
91Cerebral calcificationFAERS: 2US FAERS
92Cerebrovascular stenosisFAERS: 2US FAERS
93Coagulation time shortenedFAERS: 2US FAERS
94DeafnessFAERS: 2US FAERS
95DehydrationFAERS: 2OFFSIDES
US FAERS
96DeliriumFAERS: 2US FAERS
97Delusional disorder, unspecified typeFAERS: 2US FAERS
98Depressed Level of ConsciousnessFAERS: 2US FAERS
99Diabetes MellitusFAERS: 2US FAERS
100DiplopiaFAERS: 2US FAERS
101DisabilityFAERS: 2US FAERS
102Drug dose omissionFAERS: 2US FAERS
103EmbolismFAERS: 2US FAERS
104EpilepsyFAERS: 2US FAERS
105EructationFAERS: 2US FAERS
106Gastric ulcerFAERS: 2US FAERS
107Head discomfortFAERS: 2US FAERS
108HemiplegiaFAERS: 2US FAERS
109HerniaFAERS: 2US FAERS
110Hypoaesthesia facialFAERS: 2US FAERS
111Intracranial AneurysmFAERS: 2US FAERS
112Limb injuryFAERS: 2US FAERS
113Loose toothFAERS: 2US FAERS
114MalabsorptionFAERS: 2OFFSIDES
US FAERS
115Memory impairmentFAERS: 2US FAERS
116MeningitisFAERS: 2US FAERS
117Musculoskeletal PainFAERS: 2US FAERS
118Musculoskeletal stiffnessFAERS: 2US FAERS
119Myasthenia GravisFAERS: 2US FAERS
120MyoclonusFAERS: 2US FAERS
121NephrolithiasisFAERS: 2US FAERS
122Nerve injuryFAERS: 2US FAERS
123Night sweatsFAERS: 2US FAERS
124No adverse eventFAERS: 2US FAERS
125PancreatitisFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
126Perforated ulcerFAERS: 2US FAERS
127PetechiaeFAERS: 2US FAERS
128PresyncopeFAERS: 2US FAERS
129ProteinuriaFAERS: 2US FAERS
130RestlessnessFAERS: 2US FAERS
131Skin lesionFAERS: 2US FAERS
132SneezingFAERS: 2US FAERS
133SyncopeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
134Throat irritationFAERS: 2US FAERS
135Unresponsive to stimuliFAERS: 2US FAERS
136VertigoFAERS: 2US FAERS
137Visual ImpairmentFAERS: 2US FAERS
138Wrong technique in product usage processFAERS: 2US FAERS
139nervous system disorderFAERS: 2US FAERS
140Abdominal massFAERS: 1US FAERS
141Abnormal weight gainFAERS: 1US FAERS
142Accidental drug intake by childFAERS: 1US FAERS
143Accidental overdoseFAERS: 1US FAERS
144Anaphylactic shockFAERS: 1US FAERS
145AngerFAERS: 1US FAERS
146AngioedemaFAERS: 1US FAERS
147Aortic AneurysmFAERS: 1US FAERS
148AphagiaFAERS: 1US FAERS
149Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
150Band neutrophil count increasedFAERS: 1US FAERS
151Basal cell carcinomaFAERS: 1US FAERS
152BedriddenFAERS: 1US FAERS
153BlindnessFAERS: 1US FAERS
154Blood count abnormalFAERS: 1US FAERS
155Blood creatine phosphokinase MBFAERS: 1US FAERS
156Blood creatine phosphokinase increasedFAERS: 1US FAERS
157Blood creatinine decreasedFAERS: 1US FAERS
158Blood urea increasedFAERS: 1OFFSIDES
US FAERS
159Body height below normalFAERS: 1US FAERS
160BradycardiaFAERS: 112093268CTD
OFFSIDES
US FAERS
161BronchospasmFAERS: 1US FAERS
162Candida test positiveFAERS: 1US FAERS
163Carcinoma in situ of skinFAERS: 1US FAERS
164Cataract operationFAERS: 1US FAERS
165CataractFAERS: 1US FAERS
166Cauda Equina SyndromeFAERS: 1US FAERS
167Central nervous system lesionFAERS: 1US FAERS
168Cerebellar infarctionFAERS: 1US FAERS
169Cerebral ThrombosisFAERS: 1US FAERS
170Cerebral microhaemorrhageFAERS: 1US FAERS
171CholecystitisFAERS: 1US FAERS
172Coronary Artery DiseaseFAERS: 1US FAERS
173Coronary artery reocclusionFAERS: 1US FAERS
174CryingFAERS: 1US FAERS
175CyanosisFAERS: 1US FAERS
176CystFAERS: 1US FAERS
177Dark circles under eyesFAERS: 1US FAERS
178Depressed moodFAERS: 1OFFSIDES
US FAERS
179DermatitisFAERS: 1US FAERS
180Disease ProgressionFAERS: 1US FAERS
181DisorientationFAERS: 1US FAERS
182DissociationFAERS: 1US FAERS
183Drug abuserFAERS: 1US FAERS
184Drug abuseFAERS: 1US FAERS
185Drug administration errorFAERS: 1US FAERS
186Drug level decreasedFAERS: 1US FAERS
187Drug prescribing errorFAERS: 1US FAERS
188Drug withdrawal headacheFAERS: 1US FAERS
189Duodenal UlcerFAERS: 1US FAERS
190Economic problemFAERS: 1US FAERS
191EczemaFAERS: 1US FAERS
192EpiglottitisFAERS: 1US FAERS
193Erosive DuodenitisFAERS: 1US FAERS
194Eye painFAERS: 1US FAERS
195Facial PainFAERS: 1US FAERS
196Feeling ColdFAERS: 1US FAERS
197Full blood count decreasedFAERS: 1OFFSIDES
US FAERS
198Gastrointestinal infectionFAERS: 1US FAERS
199General physical conditionFAERS: 1US FAERS
200GlaucomaFAERS: 1US FAERS
201Global AmnesiaFAERS: 1US FAERS
202Glossopharyngeal NeuralgiaFAERS: 1US FAERS
203HepatotoxicityFAERS: 1US FAERS
204HyperparathyroidismFAERS: 1US FAERS
205Hypertensive crisisFAERS: 1US FAERS
206IncoherentFAERS: 1US FAERS
207Incorrect drug dosage form administeredFAERS: 1US FAERS
208Incorrect product storageFAERS: 1US FAERS
209Incorrect route of drug administrationFAERS: 1US FAERS
210Incorrect storage of drugFAERS: 1US FAERS
211Increased tendency to bruiseFAERS: 1US FAERS
212Intentional product use issueFAERS: 1US FAERS
213Intercepted drug dispensing errorFAERS: 1US FAERS
214Intestinal ObstructionFAERS: 1US FAERS
215Intestinal infarctionFAERS: 1US FAERS
216LacerationFAERS: 1US FAERS
217Large intestine perforationFAERS: 1US FAERS
218LethargyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
219Leukocytoclastic vasculitisFAERS: 1US FAERS
220Limb discomfortFAERS: 1US FAERS
221Limb operationFAERS: 1US FAERS
222Lip swellingFAERS: 1US FAERS
223Livedo ReticularisFAERS: 1US FAERS
224Lower respiratory tract infectionFAERS: 1US FAERS
225MalariaFAERS: 1US FAERS
226MastocytosisFAERS: 1US FAERS
227Medication residue presentFAERS: 1US FAERS
228MenorrhagiaFAERS: 1US FAERS
229MetrorrhagiaFAERS: 1US FAERS
230Mood swingsFAERS: 1US FAERS
231NervousnessFAERS: 1US FAERS
232Neutrophil count decreasedFAERS: 1US FAERS
233Ocular discomfortFAERS: 1US FAERS
234OliguriaFAERS: 1US FAERS
235Oropharyngeal painFAERS: 1US FAERS
236Orthostatic hypertensionFAERS: 1US FAERS
237Pancreatic carcinomaFAERS: 1US FAERS
238Periorbital contusionFAERS: 1US FAERS
239Peripheral swellingFAERS: 1US FAERS
240Pharmaceutical product complaintFAERS: 1US FAERS
241Platelet count abnormalFAERS: 1US FAERS
242PolydipsiaFAERS: 1US FAERS
243Post procedural complicationFAERS: 1US FAERS
244Prescribed overdoseFAERS: 1US FAERS
245Product expiration date issueFAERS: 1US FAERS
246Product quality control issueFAERS: 1US FAERS
247Product solubility abnormalFAERS: 1US FAERS
248Product storage errorFAERS: 1US FAERS
249Pulmonary HypertensionFAERS: 1US FAERS
250Pulmonary thrombosisFAERS: 1US FAERS
251Rash erythematousFAERS: 1US FAERS
252Renal cancer metastaticFAERS: 1US FAERS
253Retrograde amnesiaFAERS: 1US FAERS
254Rubber sensitivityFAERS: 1US FAERS
255SarcomaFAERS: 1US FAERS
256ScabFAERS: 1US FAERS
257ShockFAERS: 1US FAERS
258Sinus TachycardiaFAERS: 1US FAERS
259SinusitisFAERS: 1US FAERS
260Skin UlcerFAERS: 1US FAERS
261Skin reactionFAERS: 1US FAERS
262SomnambulismFAERS: 1US FAERS
263Spinal column stenosisFAERS: 1US FAERS
264Sputum retentionFAERS: 1US FAERS
265StenosisFAERS: 1US FAERS
266SunburnFAERS: 1US FAERS
267Thrombocytopenic purpuraFAERS: 1US FAERS
268Tooth ExtractionFAERS: 1US FAERS
269Tooth InfectionFAERS: 1US FAERS
270Tooth LossFAERS: 1US FAERS
271ToothacheFAERS: 1US FAERS
272TremorFAERS: 1US FAERS
273UlcerFAERS: 1OFFSIDES
US FAERS
274Urinary IncontinenceFAERS: 1US FAERS
275Urine output increasedFAERS: 1US FAERS
276Uterine PolypFAERS: 1US FAERS
277Uterine ProlapseFAERS: 1US FAERS
278Vascular occlusionFAERS: 1US FAERS
279VasculitisFAERS: 1US FAERS
280Venous ThrombosisFAERS: 1US FAERS
281Vessel perforationFAERS: 1US FAERS
282Vulvovaginal burning sensationFAERS: 1US FAERS
283WheezingFAERS: 1US FAERS
284White blood cell count decreasedFAERS: 1US FAERS
285Wrong drug administeredFAERS: 1US FAERS
286jaundiceFAERS: 1US FAERS
287AbuliaOFFSIDES
288Acute kidney injuryCanada Vigilance: 1Canada Vigilance
289AdenocarcinomaOFFSIDES
290AgraphiaOFFSIDES
291AnorexiaOFFSIDES
292Blood albumin decreasedOFFSIDES
293Blood amylase decreasedOFFSIDES
294Blood chloride decreasedOFFSIDES
295Blood creatinine increasedOFFSIDES
296Blood folate increasedOFFSIDES
297Blood iron decreasedOFFSIDES
298Blood sodiumOFFSIDES
299Bone marrow myelogram abnormalOFFSIDES
300Cardiac Tamponade3871322CTD
301Cardioactive drug level increasedOFFSIDES
302Cardiomyopathies17541306CTD
303Cardiovascular Diseases16211203CTD
304CellulitisOFFSIDES
305Chemotherapeutic drug level increasedOFFSIDES
306CholangiolitisOFFSIDES
307Chronic left ventricular failureOFFSIDES
308DiarrheaOFFSIDES
309DiscomfortCanada Vigilance: 1Canada Vigilance
310Gamma-Glutamyltransferase IncreasedOFFSIDES
311GastritisCanada Vigilance: 1Canada Vigilance
312Gastrointestinal Hemorrhage7032379CTD
313General physical health deteriorationOFFSIDES
314Hemorrhage9025160CTD
315HepatitisOFFSIDES
316HiccoughOFFSIDES
317Intention tremorOFFSIDES
318Kidney FailureOFFSIDES
319Myocardial Ischemia17541306CTD
320Occult blood positiveOFFSIDES
321Oropharyngeal discomfortOFFSIDES
322PanophthalmitisOFFSIDES
323Pericardial effusion8299624CTD
324Purpura, Thrombotic Thrombocytopenic7032379CTD
325PyelonephritisOFFSIDES
326Subarachnoid Hemorrhage7032379CTD
327Supraventricular tachycardiaOFFSIDES
328Ventricular Dysfunction, Left17541306CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.